Literature DB >> 31464350

Associations between cerebrovascular risk factors and parkinson disease.

Benjamin R Kummer1, Iván Diaz2, Xian Wu2, Ashley E Aaroe1, Monica L Chen1, Costantino Iadecola1, Hooman Kamel1, Babak B Navi1.   

Abstract

OBJECTIVE: To determine whether cerebrovascular risk factors are associated with subsequent diagnoses of Parkinson disease, and whether these associations are similar in magnitude to those with subsequent diagnoses of Alzheimer disease.
METHODS: This was a retrospective cohort study using claims data from a 5% random sample of Medicare beneficiaries from 2008 to 2015. The exposures were stroke, atrial fibrillation, coronary disease, hyperlipidemia, hypertension, sleep apnea, diabetes mellitus, heart failure, peripheral vascular disease, chronic kidney disease, chronic obstructive pulmonary disease, valvular heart disease, tobacco use, and alcohol abuse. The primary outcome was a new diagnosis of idiopathic Parkinson disease. The secondary outcome was a new diagnosis of Alzheimer disease. Marginal structural Cox models adjusting for time-dependent confounding were used to characterize the association between exposures and outcomes. We also evaluated the association between cerebrovascular risk factors and subsequent renal colic (negative control).
RESULTS: Among 1,035,536 Medicare beneficiaries followed for a mean of 5.2 years, 15,531 (1.5%) participants were diagnosed with Parkinson disease and 81,974 (7.9%) were diagnosed with Alzheimer disease. Most evaluated cerebrovascular risk factors, including prior stroke (hazard ratio = 1.55; 95% confidence interval = 1.39-1.72), were associated with the subsequent diagnosis of Parkinson disease. The magnitudes of these associations were similar, but attenuated, to the associations between cerebrovascular risk factors and Alzheimer disease. Confirming the validity of our analytical model, most cerebrovascular risk factors were not associated with the subsequent diagnosis of renal colic.
INTERPRETATION: Cerebrovascular risk factors are associated with Parkinson disease, an effect comparable to their association with Alzheimer disease. ANN NEUROL 2019;86:572-581.
© 2019 American Neurological Association.

Entities:  

Year:  2019        PMID: 31464350      PMCID: PMC6951811          DOI: 10.1002/ana.25564

Source DB:  PubMed          Journal:  Ann Neurol        ISSN: 0364-5134            Impact factor:   10.422


  50 in total

1.  History of vascular disease and mild parkinsonian signs in community-dwelling elderly individuals.

Authors:  Elan D Louis; Jose A Luchsinger
Journal:  Arch Neurol       Date:  2006-05

2.  Survival after open versus endovascular thoracic aortic aneurysm repair in an observational study of the Medicare population.

Authors:  Philip P Goodney; Lori Travis; F Lee Lucas; Mark F Fillinger; David C Goodman; Jack L Cronenwett; David H Stone
Journal:  Circulation       Date:  2011-11-21       Impact factor: 29.690

Review 3.  Morphologic diagnosis of "vascular dementia" - a critical update.

Authors:  Kurt A Jellinger
Journal:  J Neurol Sci       Date:  2008-05-02       Impact factor: 3.181

4.  Clinicopathological investigation of vascular parkinsonism, including clinical criteria for diagnosis.

Authors:  Jan C M Zijlmans; Susan E Daniel; Andrew J Hughes; Tamas Révész; Andrew J Lees
Journal:  Mov Disord       Date:  2004-06       Impact factor: 10.338

5.  Clinicoradiological comparison between vascular parkinsonism and Parkinson's disease.

Authors:  Thiago Cardoso Vale; Paulo Caramelli; Francisco Cardoso
Journal:  J Neurol Neurosurg Psychiatry       Date:  2014-07-08       Impact factor: 10.154

6.  Pooled analysis of tobacco use and risk of Parkinson disease.

Authors:  Beate Ritz; Alberto Ascherio; Harvey Checkoway; Karen S Marder; Lorene M Nelson; Walter A Rocca; G Webster Ross; Daniel Strickland; Stephen K Van Den Eeden; Jay Gorell
Journal:  Arch Neurol       Date:  2007-07

7.  Kidney stones and the risk for chronic kidney disease.

Authors:  Andrew D Rule; Eric J Bergstralh; L Joseph Melton; Xujian Li; Amy L Weaver; John C Lieske
Journal:  Clin J Am Soc Nephrol       Date:  2009-04-01       Impact factor: 8.237

8.  The Role of Cardiovascular Risk Factors and Stroke in Familial Alzheimer Disease.

Authors:  Giuseppe Tosto; Thomas D Bird; David A Bennett; Bradley F Boeve; Adam M Brickman; Carlos Cruchaga; Kelley Faber; Tatiana M Foroud; Martin Farlow; Alison M Goate; Neill R Graff-Radford; Rafael Lantigua; Jennifer Manly; Ruth Ottman; Roger Rosenberg; Daniel J Schaid; Nicole Schupf; Yaakov Stern; Robert A Sweet; Richard Mayeux
Journal:  JAMA Neurol       Date:  2016-10-01       Impact factor: 18.302

Review 9.  Diabetes and risk of Parkinson's disease: a systematic review and meta-analysis.

Authors:  Emanuele Cereda; Michela Barichella; Carlo Pedrolli; Catherine Klersy; Erica Cassani; Riccardo Caccialanza; Gianni Pezzoli
Journal:  Diabetes Care       Date:  2011-12       Impact factor: 19.112

10.  Prospective cohort study of type 2 diabetes and the risk of Parkinson's disease.

Authors:  Jane A Driver; Ashley Smith; Julie E Buring; J Michael Gaziano; Tobias Kurth; Giancarlo Logroscino
Journal:  Diabetes Care       Date:  2008-07-03       Impact factor: 19.112

View more
  16 in total

1.  Development of Parkinson Disease and Its Relationship with Incidentally Discovered White Matter Disease and Covert Brain Infarction in a Real-World Cohort.

Authors:  David M Kent; Lester Y Leung; Eric J Puttock; Andy Y Wang; Patrick H Luetmer; David F Kallmes; Jason Nelson; Sunyang Fu; Chengyi Zheng; Ellen M Vickery; Hongfang Liu; Alastair J Noyce; Wansu Chen
Journal:  Ann Neurol       Date:  2022-08-17       Impact factor: 11.274

Review 2.  Cardiovascular Risk Stratification in Diabetic Retinopathy via Atherosclerotic Pathway in COVID-19/Non-COVID-19 Frameworks Using Artificial Intelligence Paradigm: A Narrative Review.

Authors:  Smiksha Munjral; Mahesh Maindarkar; Puneet Ahluwalia; Anudeep Puvvula; Ankush Jamthikar; Tanay Jujaray; Neha Suri; Sudip Paul; Rajesh Pathak; Luca Saba; Renoh Johnson Chalakkal; Suneet Gupta; Gavino Faa; Inder M Singh; Paramjit S Chadha; Monika Turk; Amer M Johri; Narendra N Khanna; Klaudija Viskovic; Sophie Mavrogeni; John R Laird; Gyan Pareek; Martin Miner; David W Sobel; Antonella Balestrieri; Petros P Sfikakis; George Tsoulfas; Athanasios Protogerou; Durga Prasanna Misra; Vikas Agarwal; George D Kitas; Raghu Kolluri; Jagjit Teji; Mustafa Al-Maini; Surinder K Dhanjil; Meyypan Sockalingam; Ajit Saxena; Aditya Sharma; Vijay Rathore; Mostafa Fatemi; Azra Alizad; Vijay Viswanathan; Padukode R Krishnan; Tomaz Omerzu; Subbaram Naidu; Andrew Nicolaides; Mostafa M Fouda; Jasjit S Suri
Journal:  Diagnostics (Basel)       Date:  2022-05-14

3.  Tai Chi exercise improves age-associated decline in cerebrovascular function: a cross-sectional study.

Authors:  Lili Li; Jingjing Wang; Shaoying Guo; Yangqi Xing; Xiongwen Ke; Yinghao Chen; Yuan He; Shun Wang; Jiayu Wang; Xinwu Cui; Zhihua Wang; Lixu Tang
Journal:  BMC Geriatr       Date:  2021-05-06       Impact factor: 3.921

4.  Effect of cerebral small vessel disease on cognitive impairment in Parkinson's disease: a systematic review and meta-analysis.

Authors:  Huijuan Wan; Guangyao Wang; Qi Liu; Yilong Wang
Journal:  Ann Transl Med       Date:  2022-03

5.  Current and projected future economic burden of Parkinson's disease in the U.S.

Authors:  Wenya Yang; Jamie L Hamilton; Catherine Kopil; James C Beck; Caroline M Tanner; Roger L Albin; E Ray Dorsey; Nabila Dahodwala; Inna Cintina; Paul Hogan; Ted Thompson
Journal:  NPJ Parkinsons Dis       Date:  2020-07-09

6.  Case-control study of hypertension and Parkinson's disease.

Authors:  Yuen-Fann Ng; Ebonne Ng; Ee-Wei Lim; Kumar M Prakash; Louis C S Tan; Eng-King Tan
Journal:  NPJ Parkinsons Dis       Date:  2021-07-21

7.  Vascular, inflammatory and metabolic risk factors in relation to dementia in Parkinson's disease patients with type 2 diabetes mellitus.

Authors:  Ting Wang; Feilan Yuan; Zhenze Chen; Shuzhen Zhu; Zihan Chang; Wanlin Yang; Bin Deng; Rongfang Que; Peihua Cao; Yinxia Chao; Lingling Chan; Ying Pan; Yanping Wang; Linting Xu; Qiurong Lyu; Piu Chan; Midori A Yenari; Eng-King Tan; Qing Wang
Journal:  Aging (Albany NY)       Date:  2020-08-15       Impact factor: 5.682

Review 8.  Gut Microbiota Approach-A New Strategy to Treat Parkinson's Disease.

Authors:  Jing Liu; Fei Xu; Zhiyan Nie; Lei Shao
Journal:  Front Cell Infect Microbiol       Date:  2020-10-22       Impact factor: 5.293

Review 9.  Common Protective Strategies in Neurodegenerative Disease: Focusing on Risk Factors to Target the Cellular Redox System.

Authors:  Patrizia Hrelia; Giulia Sita; Marina Ziche; Emma Ristori; Angela Marino; Marika Cordaro; Raffaella Molteni; Vittoria Spero; Marco Malaguti; Fabiana Morroni; Silvana Hrelia
Journal:  Oxid Med Cell Longev       Date:  2020-08-01       Impact factor: 6.543

10.  Elevated HDL Levels Linked to Poorer Cognitive Ability in Females With Parkinson's Disease.

Authors:  Megan C Bakeberg; Anastazja M Gorecki; Jade E Kenna; Alexa Jefferson; Michelle Byrnes; Soumya Ghosh; Malcolm K Horne; Sarah McGregor; Rick Stell; Sue Walters; Frank L Mastaglia; Ryan S Anderton
Journal:  Front Aging Neurosci       Date:  2021-06-11       Impact factor: 5.750

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.